These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21632871)
61. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation. Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316 [TBL] [Abstract][Full Text] [Related]
62. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Nallathambi J; Laissue P; Batista F; Benayoun BA; Lesaffre C; Moumné L; Pandaranayaka PE; Usha K; Krishnaswamy S; Sundaresan P; Veitia RA Hum Mutat; 2008 Aug; 29(8):E123-31. PubMed ID: 18484667 [TBL] [Abstract][Full Text] [Related]
63. Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems. Dipietromaria A; Benayoun BA; Todeschini AL; Rivals I; Bazin C; Veitia RA Hum Mol Genet; 2009 Sep; 18(17):3324-33. PubMed ID: 19515849 [TBL] [Abstract][Full Text] [Related]
64. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients. Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839 [TBL] [Abstract][Full Text] [Related]
65. Mutational probing of the forkhead domain of the transcription factor FOXL2 provides insights into the pathogenicity of naturally occurring mutations. Todeschini AL; Dipietromaria A; L'hôte D; Boucham FZ; Georges AB; Pandaranayaka PJ; Krishnaswamy S; Rivals I; Bazin C; Veitia RA Hum Mol Genet; 2011 Sep; 20(17):3376-85. PubMed ID: 21632871 [TBL] [Abstract][Full Text] [Related]
66. The mutations and potential targets of the forkhead transcription factor FOXL2. Moumné L; Batista F; Benayoun BA; Nallathambi J; Fellous M; Sundaresan P; Veitia RA Mol Cell Endocrinol; 2008 Jan; 282(1-2):2-11. PubMed ID: 18155828 [TBL] [Abstract][Full Text] [Related]
67. FOXL2 mutations and genomic rearrangements in BPES. Beysen D; De Paepe A; De Baere E Hum Mutat; 2009 Feb; 30(2):158-69. PubMed ID: 18726931 [TBL] [Abstract][Full Text] [Related]
68. Foxl2 function in ovarian development. Uhlenhaut NH; Treier M Mol Genet Metab; 2006 Jul; 88(3):225-34. PubMed ID: 16647286 [TBL] [Abstract][Full Text] [Related]
69. The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology. Caburet S; Georges A; L'Hôte D; Todeschini AL; Benayoun BA; Veitia RA Mol Cell Endocrinol; 2012 Jun; 356(1-2):55-64. PubMed ID: 21763750 [TBL] [Abstract][Full Text] [Related]